In this issue of Danish Pharmacovigilance Update:
News from the EU
- Filgrastim (Neupogen) and pegfilgrastim (Neulasta) are associated with risk of capillary leak syndrome
- Use of bromocriptine (Parlodel®) for prevention or suppression of lactation is to be reassessed
- Pregnancy prevention programme during treatment with Erivedge
- Risk of hypermagnesaemia from the use of the parenteral nutrition preparations Numeta G13E and G16E
- Be aware of the bleeding risk factors associated with the use of the new oral anticoagulants Eliquis®, Pradaxa® and Xarelto®
- Lariam® and neuropsychiatric adverse reactions
- Use of short-acting beta-agonists for obstetric indications
News from the Danish Health and Medicines Authority
- Psychotic or manic symptoms emerging during use of methylphenidate and atomoxetine
- Adverse reaction reports concerning the HPV vaccine from 1 January through 9 September 2013